Cytosorbents (CTSO) Cash from Operations (2010 - 2026)
Cytosorbents (CTSO) posted Cash from Operations of 1162000.0 for Q1 2026, up 75.92% on a QoQ basis from 4825000.0 in Q4 2025, and up 66.47% year-over-year from 698005.55 in Q1 2025.
Cytosorbents (CTSO) Cash from Operations (2010 - 2026) Analysis & Trends
Cytosorbents' Cash from Operations history runs 17 years deep, the most recent figure standing at 1162000.0 for Q1 2026.
- Quarterly Cash from Operations rose 66.47% year-over-year to 1162000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10073000.0 (up 22.9% YoY) and the FY2025 annual result came in at 12377000.0, up 14.22% from the prior year.
- Cash from Operations was 1162000.0 for Q1 2026 at Cytosorbents, up from 4825000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 1162000.0 in Q1 2026 and bottomed at 8119170.0 in Q1 2022.
- A 5-year average of 4579789.29 and a median of 4825000.0 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations plunged 294.84% — and 2025, when it surged 68.52%.
- Cytosorbents' Cash from Operations stood at 5340327.0 in 2022, then slipped by 19.98% to 6407411.0 in 2023, then surged by 63.46% to 2341000.0 in 2024, then slumped by 106.11% to 4825000.0 in 2025, then jumped by 75.92% to 1162000.0 in 2026.
- Business Quant data shows CTSO's Cash from Operations at 1162000.0 in Q1 2026, 4825000.0 in Q4 2025, and 2577000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | -1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.16 Mn |
| Mar 31, 2026 | -1.16 Mn |
| Dec 31, 2025 | -4.83 Mn |
| Dec 31, 2025 | -4.83 Mn |
| Sep 30, 2025 | -2.58 Mn |
| Sep 30, 2025 | -2.58 Mn |
| Jun 30, 2025 | -1.51 Mn |
| Jun 30, 2025 | -1.51 Mn |
| Mar 31, 2025 | -3.47 Mn |
| Mar 31, 2025 | -3.47 Mn |
| Dec 31, 2024 | -2.34 Mn |
| Dec 31, 2024 | -2.34 Mn |
| Sep 30, 2024 | -2.46 Mn |
| Sep 30, 2024 | -2.46 Mn |
| Jun 30, 2024 | -4.79 Mn |
| Jun 30, 2024 | -4.79 Mn |
| Mar 31, 2024 | -4.83 Mn |
| Mar 31, 2024 | -4.83 Mn |
| Dec 31, 2023 | -6.41 Mn |
| Dec 31, 2023 | -6.41 Mn |